Ertaczo (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Ertaczo drug offered from Valeant Pharmaceuticals North America LLC. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: Sertaconazole Nitrate
SUBSTANCE NAME: SERTACONAZOLE NITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Azole Antifungal [EPC],Azoles [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-12-10
END MARKETING DATE: 0000-00-00


Ertaczo HUMAN PRESCRIPTION DRUG Details:

Item DescriptionErtaczo from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/g)
START MARKETING DATE: 2003-12-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-5115_152e65eb-3bdb-4062-9c3f-168f3806b51d
PRODUCT NDC: 0187-5115
APPLICATION NUMBER: NDA021385

Other SERTACONAZOLE NITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rebel Distributors Corp.ERTACZO
Valeant Pharmaceuticals North America LLCErtaczo